MICHELLE LAMM: Open Payments
NPI 1982060166 · GREENSBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 21 payments from 12 companies in 2025. Trend: 2023 $305 · 2024 $737 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Esperion Therapeutics, Inc. | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Corcept Therapeutics | 2 | $47 |
| Dexcom, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Senseonics, Incorporated | 1 | $36 |
| Abbott Laboratories | 1 | $26 |
Products named: LEQVIO, NEXLETOL, VERQUVO, Korlym, Dexcom G6 Transmitter, FARXIGA, Eversense, Wegovy.
Industry payments across GA — which companies pay providers there.
